Epsilon Healthcare Limited
Epsilon Healthcare Limited, together with its subsidiaries, engages in the healthcare business in Australia. The company operates in two segments, Contract Development and Manufacturing Activities; and Telehealth Medical Practice Services. It is involved in the healthcare and clinics operation; pharmaceutical contract development and manufacturing; development and manufacturing of active pharmace… Read more
Market Cap & Net Worth: Epsilon Healthcare Limited (HDRPF)
Epsilon Healthcare Limited (PINK:HDRPF) has a market capitalization of $544.75K ($544.75K) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #38252 globally and #12448 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Epsilon Healthcare Limited's stock price $0.00 by its total outstanding shares 389104011 (389.10 Million).
Epsilon Healthcare Limited Market Cap History: 2018 to 2025
Epsilon Healthcare Limited's market capitalization history from 2018 to 2025. Data shows change from $133.07 Million to $544.75K (-57.76% CAGR).
Epsilon Healthcare Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Epsilon Healthcare Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.10x
Epsilon Healthcare Limited's market cap is 0.10 times its annual revenue
1.02x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2018 | $133.07 Million | $2.66 Million | -$8.61 Million | 49.95x | N/A |
| 2019 | $112.84 Million | $4.79 Million | -$11.68 Million | 23.55x | N/A |
| 2020 | $64.20 Million | $7.36 Million | -$10.95 Million | 8.72x | N/A |
| 2021 | $91.44 Million | $5.50 Million | -$8.91 Million | 16.63x | N/A |
| 2022 | $3.89 Million | $7.11 Million | -$13.29 Million | 0.55x | N/A |
| 2023 | $3.89 Million | $6.65 Million | -$1.09 Million | 0.58x | N/A |
| 2024 | $544.75K | $5.60 Million | -$2.01 Million | 0.10x | N/A |
Competitor Companies of HDRPF by Market Capitalization
Companies near Epsilon Healthcare Limited in the global market cap rankings as of March 19, 2026.
Key companies related to Epsilon Healthcare Limited by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Epsilon Healthcare Limited Historical Marketcap From 2018 to 2025
Between 2018 and today, Epsilon Healthcare Limited's market cap moved from $133.07 Million to $ 544.75K, with a yearly change of -57.76%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $544.75K | 0.00% |
| 2024 | $544.75K | -86.00% |
| 2023 | $3.89 Million | 0.00% |
| 2022 | $3.89 Million | -95.74% |
| 2021 | $91.44 Million | +42.42% |
| 2020 | $64.20 Million | -43.10% |
| 2019 | $112.84 Million | -15.20% |
| 2018 | $133.07 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Epsilon Healthcare Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $544.75K USD |
| MoneyControl | $544.75K USD |
| MarketWatch | $544.75K USD |
| marketcap.company | $544.75K USD |
| Reuters | $544.75K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.